Search Within
Document Type
629-94-7
Keyword:'629-94-7'
Showing 1-21 of 21 results for "629-94-7" within Technical Documents
Product Information Sheet-P4406
Spring Harbor, NY), pp. 628-629
(1988).
14. Newkirk, M. M. et al., Hybridoma, 6(5), 453-460
(1987).
15. Tacias-Pascacio, V. G. et al., Int. J. Biol.
Macromol., 188, 94-113 (2021).
Notice
We
Phosphospecific monoclonal antibodies to Catenin transmembrane signaling and gene expression markers
., 10, 629-639 (1998).
2. Edelman, G.M. and Crossin, K.L., Annu. Rev. Biochem., 60, 155-190 (1991).
3. Takeichi, M., Science, 251, 1451-1455 (1991).
4. Nagafuchi, A. and Takeichi, M., EMBO J., 7, 3679-3684
Monoclonal Anti-phospho-b-Catenin (pSer33) antibody produced in mouse (C2363)
dilutions by titration.
References
1. Ben-Ze’ev, A., and Geiger, B., Curr. Opin. Cell
Biol., 10, 629-639 (1998).
2. Edelman, G.M., and Crossin, K.L., Annu. Rev.
Biochem., 60, 155-190 (1991).
3.
Monoclonal Anti-phospho-b-Catenin (pSer33/pSer37) antibody produced in mouse (C4231)
10, 629-639 (1998).
4. Edelman, G.M., and Crossin, K.L., Annu. Rev.
Biochem., 60, 155-190 (1991).
5. Takeichi, M., Science, 251, 1451-1455 (1991).
6. Nagafuchi, A., and Takeichi, M., EMBO J., 7, 3679
XP725 Antibody Number-Lot Number 071M4826
577 578 579 580 601 602 603 604 625 626 627 628 649 650 651 652
7.2 581 582 583 584 605 606 607 608 629 630 631 632 653 654 655 656
7.3 585 586 587 588 609 610 611 612
MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors
143 44 71 31 88 46 161 71
std 3 212 150 94 58 354 227 157 310 133 155 53 243 95 258 333
std 4 750 849 307 411 1,154 736 524 906 495 493 155
Protein Tyrosine Phosphatases- Potential Roles in Disease
10. Alexander, D.R., Semin. Immunol., 12, 349-359 (2000).
11. Binstadt, B.A., et al., Immunity, 5, 629-638 (1996).
12. Van Leishout, E.M., et al., Neuroscience, 102, 833-841 (2001).
13. Wallace, M.J., et
Corticotropin-Releasing Factor Receptor Antagonists- Potential Novel Therapies for Human Disease
J.W., et al., Peptides, 22, 845-851 (2001).
98. Bremner, J.D., et al., Am. J. Psychiatry, 154, 624-629 (1997).
99. Griebel, G., et al., Psychopharmacology (Berl) , 138, 55-66 (1998).
100. Gorman, J.M.
Reprint: Industrial application of impurity flocculation to streamline antibody purification processes
J, Wang D. Induced flocculation of animal cells in
suspension culture. Biotechnol. Bioeng. 34(5), 629–638 (1989).
19 Tomic S, Besnard L, Fürst B et al. Complete clarification
solution for processing
Material Matters Vol. 1, No. 1
et
al. Chem. Mater. �00�, 14, 656. (6) Bowden, M. et al. J. Photopolym. Sci.
Technol. �00�, 16, 629. (7) Avgeropoulos, A. et al. Chem. Mater. 1998, 10,
2109. (8) Chan, V. Z.-H. et al. L. Science 1999
XP725 Antibody List Lot 089K4791
R7904 5868 RAB5A M NP_004153.2 y y y
628 Rad17 (C-terminal) R8029 5884 RAD17 P NP_002864.1 y n/d n/d
629 Raf-1/c-Raf R2404 5894 RAF1 M NP_002871.1 y y y
630 Raf-1 R5773 5894 RAF1 P NP_002871.1 y n/d y
634
XP725 Antibody List Lot 129K4831
R7904 5868 RAB5A M NP_004153.2 y y y
628 Rad17 (C-terminal) R8029 5884 RAD17 P NP_002864.1 y n/d n/d
629 Raf-1/c-Raf R2404 5894 RAF1 M NP_002871.1 y y y
630 Raf-1 R5773 5894 RAF1 P NP_002871.1 y n/d y
634
XP725 Antibody List Lot 129K4830
R7904 5868 RAB5A M NP_004153.2 y y y
628 Rad17 (C-terminal) R8029 5884 RAD17 P NP_002864.1 y n/d n/d
629 Raf-1/c-Raf R2404 5894 RAF1 M NP_002871.1 y y y
630 Raf-1 R5773 5894 RAF1 P NP_002871.1 y n/d y
634
XP725 Worksheet for Lot Number 071M4826
2 GRP75 G4170
627 4 2 1 3 GRP78 BiP G8918
628 4 2 1 4 GRP78 BiP G8918
629 4 2 1 5 GRP94 G4420
630 4 2 1 6 GRP94 G4420
631 4 2 1 7 hABH1 A8103
632 4 2 1 8 hABH1
List of Antibodies
Anti Cy3+Cy5 C0992 M NA NA NA
625 Rab 7 R8779 M y y y
626 Rab9 R5404 M y y y
627 RAD1 R5029 P y n/d n/d
628 Rad17 (C-terminal) (C-terminal) R8029 P y n/d n/d
629 Raf-1/c-Raf R2404 M y y y
630
3D BIOPRINTING: Printing a Brighter Future
Ren, B.; Yuan, G.; Jia, Y.; Li, J.; Xiong, D.;
Xing, X.; Niu, X. Mater. Sci. Eng. C 2019, 101, 619–629.
(157) Gao, T.; Gillispie, G. J.; Copus, J. S.; Pr, A. K.; Seol, Y.-J.; Atala, A.; Yoo,
J.
3D BIOPRINTING: Printing a Brighter Future
Ren, B.; Yuan, G.; Jia, Y.; Li, J.; Xiong, D.;
Xing, X.; Niu, X. Mater. Sci. Eng. C 2019, 101, 619–629.
(157) Gao, T.; Gillispie, G. J.; Copus, J. S.; Pr, A. K.; Seol, Y.-J.; Atala, A.; Yoo,
J.
XP725 Antibody List
5810 RAD1 NP_596868.1 P y n/d n/d
628 Rad17 (C-terminal) R8029 5884 RAD17 NP_579922.1 P y n/d n/d
629 Raf-1/c-Raf R2404 110157, 5894, 24703 RAF1,Raf1 NP_084056.1,NP_002871.1,NP_036771.1 M y y y
630 Raf
XP725 Antibody List 013M4793
5810 RAD1 NP_596868.1 P y n/d n/d
628 Rad17 (C-terminal) R8029 5884 RAD17 NP_579922.1 P y n/d n/d
629 Raf-1/c-Raf R2404 110157, 5894, 24703 RAF1,Raf1 NP_084056.1,NP_002871.1,NP_036771.1 M y y y
630 Raf
Halal Certificate
VANILLIN 98%, FCC, FG W246409 A62715 HC-22SIVH83
628. ETHYL VINYL KETONE W338210 C29635 HC-22SIT531
629. ETHYL VINYL KETONE 95%, STABILIZED, FG W338206 B55746 HC-22SIVJ52
630. ETHYLCYCLOPENTENOLONE,NATURAL
Halal Certificate
VANILLIN 98%, FCC, FG W246409 A62715 HC-24SIAI85
628. ETHYL VINYL KETONE W338210 C29635 HC-24SIST33
629. ETHYL VINYL KETONE 95%, STABILIZED, FG W338206 B55746 HC-24SISG54
630. ETHYLCYCLOPENTENOLONE,NATURAL